An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling
Open Access
- 16 October 2008
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 27 (22) , 2955-2965
- https://doi.org/10.1038/emboj.2008.218
Abstract
Transforming growth factor (TGF)‐β induces various cellular responses principally through Smad‐dependent transcriptional regulation. Activated Smad complexes cooperate with transcription factors in regulating a group of target genes. The target genes controlled by the same Smad‐cofactor complexes are denoted a synexpression group. We found that an Id‐like helix‐loop‐helix protein, human homologue of Maid (HHM), is a synexpression group‐restricted regulator of TGF‐β signalling. HHM suppressed TGF‐β‐induced growth inhibition and cell migration but not epithelial—mesenchymal transition. In addition, HHM inhibited TGF‐β‐induced expression of plasminogen activator inhibitor‐type 1 (PAI‐1), PDGF‐B, and p21WAF, but not Snail. We identified a basic‐helix‐loop‐helix protein, Olig1, as one of the Smad‐binding transcription factors affected by HHM. Olig1 interacted with Smad2/3 in response to TGF‐β stimulation, and was involved in transcriptional activation of PAI‐1 and PDGF‐B. HHM, but not Id proteins, inhibited TGF‐β signalling‐dependent association of Olig1 with Smad2/3 through physical interaction with Olig1. HHM thus appears to regulate a subset of TGF‐β target genes including the Olig1‐Smad synexpression group. HHM is the first example of a cellular response‐selective regulator of TGF‐β signalling with clearly determined mechanisms.Keywords
This publication has 51 references indexed in Scilit:
- Rethinking scientific responsibility: Figure 1Journal of Medical Ethics, 2011
- A double-edged sword? Health research and research governance in UK primary careSocial Science & Medicine, 2009
- Aberrant DNA Methylation of OLIG1, a Novel Prognostic Factor in Non-Small Cell Lung CancerPLoS Medicine, 2007
- Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant GliomaPublished by Elsevier ,2007
- High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B GeneCancer Cell, 2007
- Myelinogenesis and Axonal Recognition by Oligodendrocytes in Brain Are Uncoupled inOlig1-Null MiceJournal of Neuroscience, 2005
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional studyBMJ, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000